Report overview
This report contains market size and forecasts of Point-of-care Cancer Screening in Global, including the following market information:
Global Point-of-care Cancer Screening Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Point-of-care Cancer Screening market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Genetic Screening Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Point-of-care Cancer Screening include Hologic Corporation, Abbott Laboratories, Qiagen N.V., F Hoffmann-La Roche, BD, Quest Diagnostics, OncoHealth Corp, Danaher and NOVIGENIX SA, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Point-of-care Cancer Screening companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Point-of-care Cancer Screening Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Point-of-care Cancer Screening Market Segment Percentages, by Type, 2022 (%)
Genetic Screening
Image Screening
Others
Global Point-of-care Cancer Screening Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Point-of-care Cancer Screening Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Point-of-care Cancer Screening Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Point-of-care Cancer Screening Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Point-of-care Cancer Screening revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Point-of-care Cancer Screening revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hologic Corporation
Abbott Laboratories
Qiagen N.V.
F Hoffmann-La Roche
BD
Quest Diagnostics
OncoHealth Corp
Danaher
NOVIGENIX SA
Quidel Corporation
